| Name | Title | Contact Details |
|---|
Cyteir is a clinical-stage oncology company that is focused on the discovery and development of next-generation synthetically lethal therapies to treat cancer. The company is using its expertise in DNA damage response biology to advance a pipeline of novel drug candidates that selectively target key cancer vulnerabilities. Cyteir`s wholly owned lead compound, CYT-0851, is a potent and selective, oral investigational drug currently in a Phase 1/2 clinical trial for hematologic and solid tumors.
PuraMed is a Schofield, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Solutions connectées pour le diagnostic médical
Armada Health Care is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
Maclean Health is a medical and pharmaceutical products wholesale distributor that specializes in supplying market innovators to government and private healthcare partners.